Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Clasificación en acciones #13762
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Precio por acción
$0.85814713
Última sincronización: 2025-05-14
Capitalización bursátil
$463.40M
Cambio (1 día)
-2.52%
Cambio (1 año)
0.00%
País
GB
Comercio Alliance Pharma plc (APH)

Categoría

Ganancias de Alliance Pharma plc (APH)
Ganancias en Dec 2024 TTM: $-18.14M
Secondo gli ultimi rapporti finanziari di Alliance Pharma plc, gli utili attuali della società sono $-18.14M. Nel 2023, la società ha registrato un utile di $-62.12M, una disminución en comparación con agli utili del 2022, che erano di $6.30M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Alliance Pharma plc desde 2001 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-18.14M 0.00%
2024 $-18.14M -70.79%
2023 $-62.12M -1,085.97%
2022 $6.30M -74.33%
2021 $24.55M 37.95%
2020 $17.80M -56.82%
2019 $41.21M 41.89%
2018 $29.04M -24.24%
2017 $38.34M 39.81%
2016 $27.42M 22.57%
2015 $22.37M 41.38%
2014 $15.82M -20.44%
2013 $19.89M 13.43%
2012 $17.53M 5.47%
2011 $16.62M -17.03%
2010 $20.03M 115.66%
2009 $9.29M 162.51%
2008 $3.54M -155.33%
2007 $-6.40M -762.99%
2006 $964.73K -15.19%
2005 $1.14M -128.40%
2004 $-4.01M 3,427.78%
2002 $-113.53K -162.31%
2001 $182.20K 0.00%
Ganancias de empresas similares o competidoras